SEK224.40
1.84% today
Stockholm, Nov 26, 12:52 pm CET
ISIN
SE0011205202
Symbol
VITR
Sector
Industry

Vitrolife Stock price

SEK228.60
-6.60 2.81% 1M
+42.20 22.64% 6M
+33.90 17.41% YTD
+58.30 34.23% 1Y
-291.40 56.04% 3Y
+44.90 24.44% 5Y
+199.20 677.55% 10Y
Stockholm, Closing price Mon, Nov 25 2024
+7.20 3.25%
ISIN
SE0011205202
Symbol
VITR
Sector
Industry

Key metrics

Market capitalization SEK30.95b
Enterprise Value SEK32.08b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 45.83
EV/Sales (TTM) EV/Sales 9.03
P/S ratio (TTM) P/S ratio 8.71
P/B ratio (TTM) P/B ratio 2.36
Dividend yield 0.44%
Last dividend (FY23) SEK1.00
Revenue growth (TTM) Revenue growth 2.63%
Revenue (TTM) Revenue SEK3.55b
EBIT (operating result TTM) EBIT SEK783.00m
Free Cash Flow (TTM) Free Cash Flow SEK700.00m
Cash position SEK925.00m
EPS (TTM) EPS SEK-28.10
P/E forward 58.62
P/S forward 8.61
EV/Sales forward 8.92
Show more

Is Vitrolife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Vitrolife Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Vitrolife forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Vitrolife forecast:

Buy
67%
Hold
33%

Financial data from Vitrolife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
3,553 3,553
3% 3%
100%
- Direct Costs 1,742 1,742
13% 13%
49%
1,811 1,811
6% 6%
51%
- Selling and Administrative Expenses 476 476
26% 26%
13%
- Research and Development Expense 114 114
6% 6%
3%
1,221 1,221
5% 5%
34%
- Depreciation and Amortization 438 438
4% 4%
12%
EBIT (Operating Income) EBIT 783 783
6% 6%
22%
Net Profit -3,805 -3,805
1,047% 1,047%
-107%

In millions SEK.

Don't miss a Thing! We will send you all news about Vitrolife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. Its products and services include oocyte retrieval needles, sperm processing, IVF media and oil, micromanipulation pipettes, labware, benchtop incubators, time-lapse systems, preimplantation genetic testing, cryopreservation, laser and imaging systems, and lab quality control systems. The firm operates through the following geographical segments: Europe, Middle East, and Africa (EMEA); North and South America; Japan and Pacific; and Asia. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Bronwyn Brophy
Employees 1,121
Founded 1989
Website www.vitrolife.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today